| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/29/2010 | US20100190185 Novel non-invasive marker for liver function and disease |
| 07/29/2010 | US20100190184 Screening method utilizing novel substrate c-ret for gamma-secretase |
| 07/29/2010 | US20100190183 Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
| 07/29/2010 | US20100190182 Diagnostic composition and method for the detection of a trichinella infection |
| 07/29/2010 | US20100190181 Biomarkers for preeclampsia |
| 07/29/2010 | US20100190180 Materials and Methods for Screening, Diagnosis and Prognosis of Conditions Associated With Stat Protein Expression |
| 07/29/2010 | US20100190177 Target activated microtransfer |
| 07/29/2010 | US20100190174 Adam12, a novel marker for abnormal cell function |
| 07/29/2010 | US20100190172 detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease |
| 07/29/2010 | US20100190165 Methods of screening compounds for bioactivity in organized tissue |
| 07/29/2010 | US20100190164 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 07/29/2010 | US20100190163 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 07/29/2010 | US20100190161 Mutations in human ubiad1 |
| 07/29/2010 | US20100190159 Fluorescence-producing molecule |
| 07/29/2010 | US20100190155 Methods and kits for measurement of lymphocyte function |
| 07/29/2010 | US20100190150 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 07/29/2010 | US20100190148 Electrophoretic Interactive Spectral Methods and Devices for the Detection and/or Characterization of Biological Particles |
| 07/29/2010 | US20100189760 Synthetic Cell Platforms and Methods of Use Thereof |
| 07/29/2010 | US20100189747 Compositions and methods for treating or preventing hiv infection |
| 07/29/2010 | US20100189738 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA |
| 07/29/2010 | US20100189724 Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189718 Molecules with extended half-lives, compositions and uses thereof |
| 07/29/2010 | US20100189713 Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation |
| 07/29/2010 | US20100189703 Non-destructive method to quantify and isolate antigen-specific b cells and uses thereof |
| 07/29/2010 | US20100189695 Irak-1 as regulator of diseases and disorders |
| 07/29/2010 | US20100189652 Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof |
| 07/29/2010 | US20100189603 Sub-micron surface plasmon resonance sensor systems |
| 07/29/2010 | US20100189601 Capillary |
| 07/29/2010 | US20100188650 Portable egg candling and containment transfer appratus and method |
| 07/29/2010 | US20100188232 Breath analyzer system and method of operating the same |
| 07/29/2010 | US20100187131 Platform technology for detecting microorganisms |
| 07/29/2010 | US20100187106 Ultra-sensitive, portable capillary sensor |
| 07/29/2010 | US20100186663 Methods and apparatus for protecting a substrate support in a semiconductor process chamber |
| 07/29/2010 | DE202009002094U1 Biofilmreaktor Biofilm reactor |
| 07/29/2010 | DE102009015945A1 Vorrichtung und Verfahren zur Abbildung der Oberfläche einer Probe Apparatus and method for imaging the surface of a sample |
| 07/29/2010 | DE102009005925A1 Device for handling bio molecules to accomplish immunoassay, has rotary encoder producing relative motion between magnetic force element and channel structure for moving magnetic particles over phase boundary of multiphase flow |
| 07/29/2010 | CA2771948A1 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
| 07/29/2010 | CA2750682A1 Functionalized microfluidic device for immunofluorescence |
| 07/29/2010 | CA2750581A1 Pta089 protein |
| 07/29/2010 | CA2750231A1 Method for identifying unknown substances by mass spectrometry |
| 07/29/2010 | CA2750076A1 Methods |
| 07/29/2010 | CA2749886A1 Methods for predicting autoimmune disease risk |
| 07/29/2010 | CA2749281A1 Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from cho cells |
| 07/29/2010 | CA2749192A1 Soluble icam-1 as biomarker for prediction of therapeutic response |
| 07/29/2010 | CA2744394A1 Selection of colorectal cancer patients for treatment with drugs targeting egfr pathway |
| 07/29/2010 | CA2743714A1 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
| 07/29/2010 | CA2718113A1 Selection of head and neck cancer patients for treatment with drugs targeting egfr pathway |
| 07/28/2010 | EP2211183A1 Method for diagnosis and monitoring of Alzheimer's disease |
| 07/28/2010 | EP2211182A1 Method for the assessment of severity of liver cirrhosis |
| 07/28/2010 | EP2211181A1 Diagnostic method for transmissible spongiform encephalopathies |
| 07/28/2010 | EP2211180A1 Use of protein SATB2 as a marker for colorectal cancer |
| 07/28/2010 | EP2211179A2 Diagnostic agent for chemotaxis |
| 07/28/2010 | EP2211178A1 Method for detecting an analyte in a sample by multiplexing FRET analysis and kit |
| 07/28/2010 | EP2211177A1 Methods using O6-alkylguanine-DNA alkyltransferases |
| 07/28/2010 | EP2211176A2 Analyzing nerve cell damage |
| 07/28/2010 | EP2211175A1 Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit |
| 07/28/2010 | EP2211174A2 Multicolored particles |
| 07/28/2010 | EP2211168A1 Method for analyzing sample and its device |
| 07/28/2010 | EP2211167A1 Method and kit for measurement of endotoxin level |
| 07/28/2010 | EP2211162A1 Method for analyzing expired air |
| 07/28/2010 | EP2210945A2 Neisseria meningitidis antigens |
| 07/28/2010 | EP2210942A1 Gene associated with liver cancer, and method for determination of the risk of acquiring liver cancer |
| 07/28/2010 | EP2210939A1 Anti-bst2 antibody |
| 07/28/2010 | EP2210938A1 Method for improving the heat stability of a composition containing glucose dehydrogenase (GDH) |
| 07/28/2010 | EP2210901A1 Antibody capable of specifically binding to a oligomer, and use thereof |
| 07/28/2010 | EP2210665A1 Apparatus for detecting target molecules |
| 07/28/2010 | EP2210268A1 Novel chemistry used in biosensors |
| 07/28/2010 | EP2210113A1 Methods for the detection of glycated hemoglobin |
| 07/28/2010 | EP2210112A1 Diagnostic methods for hiv infection |
| 07/28/2010 | EP2210111A1 Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome |
| 07/28/2010 | EP2210109A1 Preparation of samples for proteome analysis |
| 07/28/2010 | EP2210108A2 Methods for detecting major adverse cardiovascular and cerebrovascular events |
| 07/28/2010 | EP2210107A1 Methods for detecting or monitoring cancer using lpc as a marker |
| 07/28/2010 | EP2210106A1 Use of nanopatterned surfaces and method for enriching or isolating cellular subpopulations |
| 07/28/2010 | EP2210105A1 Mycobacterium antigens |
| 07/28/2010 | EP2210104A1 Cell-free methods for detecting protein-ligand interctions |
| 07/28/2010 | EP2210103A1 Method for the immobilization of a capture molecule on a solid support |
| 07/28/2010 | EP2210102A2 Edta resistant s100a12 complexes (erac) |
| 07/28/2010 | EP2210101A1 Methods and device for the detection of occult blood |
| 07/28/2010 | EP2210100A1 Improved fret-probes and use thereof |
| 07/28/2010 | EP2210099A1 Biomarkers for ovarian cancer |
| 07/28/2010 | EP2210098A1 Methods and compositions for detection and enrichment of target small rnas |
| 07/28/2010 | EP2210097A1 Method for the in vitro diagnosis and/or in-vitro therapy monitoring of infections |
| 07/28/2010 | EP2210096A1 High throughput screening method and apparatus for analysing interactions between surfaces with different topography and the environment |
| 07/28/2010 | EP2210095A1 Percutaneous biological fluid sampling and pre shaking devices and methods |
| 07/28/2010 | EP2210094A1 Test strips and system for measuring analyte levels in a fluid sample |
| 07/28/2010 | EP2210092A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 07/28/2010 | EP2210091A1 Fabric colour guide |
| 07/28/2010 | EP2210090A1 Bootstrap method for oil property prediction |
| 07/28/2010 | EP2210085A1 Apparatus and method for electrochemical detection |
| 07/28/2010 | EP2210080A2 Improved methods and devices for cellular analysis |
| 07/28/2010 | EP2209893A1 Use of aptamers in proteomics |
| 07/28/2010 | EP2209875A1 Improved detection of markers |
| 07/28/2010 | EP2209810A1 Viral therapeutic |
| 07/28/2010 | EP2209809A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 07/28/2010 | EP2209799A2 Breast cancer associated antigen |
| 07/28/2010 | EP2209549A1 Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto |
| 07/28/2010 | EP2209545A2 Extraction and purification of biological cells using ultrasound |
| 07/28/2010 | EP2209495A1 Taz/wwtr1 for diagnosis and treatment of cancer |